• Contact Us
  • About
  • Advertise
  • Careers
Kashmir Dot Com
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
Kashmir Dot Com
No Result
View All Result
Home Business

Biocon gets Health Canada nod for Yesintek autoinjector pen

Kashmir Dot Com by Kashmir Dot Com
July 29, 2026
in Business
0
Biocon gets Health Canada nod for Yesintek autoinjector pen
0
SHARES
26
VIEWS
Share on Facebook

NEW DELHI, July 29:  Biocon Ltd on Wednesday said it has received notice of compliance approval from Canadian health regulator for its Yesintek (ustekinumab) autoinjector, indicated for the treatment of moderate to severe plaque psoriasis.

The company’s subsidiary in Canada has received Notice of Compliance (NOC) approval for Yesintek (ustekinumab) Autoinjector 45 mg/0.05 mL and 90 mg/mL from Health Canada, Biocon Ltd said in a regulatory filing.

Health Canada previously granted NOC for Yesintek (solution for subcutaneous injection) 45 mg/0.5ml (prefilled syringe and vial) and 90 mg/ml (prefilled syringe) and Yesintek I.V. (solution for intravenous infusion) 130 mg/26 mL (5mg/mL) in October 2025, it added.

The availability of the Yesintek autoinjector provides patients with an option that the originator product does not offer in Canada, the company said .

The new format will allow customised treatment approaches across care settings and patient needs, it added.

Biocon said Yesintek is indicated for the treatment of moderate to severe plaque psoriasis in adult patients and in pediatric patients (6-17 years of age), active psoriatic arthritis in adults, moderately to severely active Crohn’s disease and ulcerative colitis in adults, a range of debilitating autoimmune conditions that affect thousands of Canadians.

This approval further strengthens Biocon’s portfolio of immunology products in Canada and reaffirms the company’s commitment to increasing patient access to affordable medicines around the world, a company spokesperson said. (PTI)

Tags: autoinjectorBioconCanadaHealthNOCtreatment
Previous Post

Tricolour mission: West Bengal youth on nationwide foot march reaches Ramban

Next Post

PM Extends Greetings On Tiger Day, Says Proud That India Home To 70% Of Its Global Population

Next Post
PM Extends Greetings On Tiger Day, Says Proud That India Home To 70% Of Its Global Population

PM Extends Greetings On Tiger Day, Says Proud That India Home To 70% Of Its Global Population

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

LATEST NEWS

J&K Wins Prestigious India Sports Award For “Excellence In Promoting Sports”

FDA Intensifies Food Safety Drive in J&K; Conducts 157 Inspections, Lifts 53 Samples

Chief Justice visits District Court Complex Budgam; emphasizes collective efforts to strengthen Justice System, cautious use of AI

GOC Northern Command reviews counter infiltration measures along LoC in Poonch, Sunderbani sectors

No Compromise in Delivery of Essential Public Services: DC Baramulla Directs Officers at Block Diwas

Kashmir Police Holds Third Conference on Citizen-Centric Beat Policing, Stresses SMART Policing

Dismantle Entire Terror-Separatist Ecosystem: LG Sinha to Police Officials

2-day Nature Exploration event held at Manasbal concludes

Bhupender Singh Takes Over as BSF Inspector General, Kashmir Frontier

Ladakh LG Approves Honorary Ranks for Police Personnel on Retirement

Facebook Twitter

About Us

Kashmir Dot Com (KDC) is J&K's premier News Agency having a vast reach of audience.

Kashmir Dot Com is a News Agency based in Srinagar, J&K that offers syndicated multimedia news feed to plethora of news-bureaus in J&K and beyond. We also provide a range of facilities from foreign and domestic channels to package their reports in Jammu and Kashmir. We cover almost all areas of interest in J&K to viewers including news, entertainment, and life styles, bussiness, sports, human-interest features and social and developmental issues.

KDC can well and truly take pride in the legacy of it's work, and in it's contribution towards the building of a free and fair Press in Jammu and Kashmir.

Category

  • Business
  • Entertainment
  • Health
  • JAMMU
  • Kashmir
  • Lead
  • National
  • Opinion
  • Politics
  • Science
  • Sports
  • Tech
  • Uncategorized
  • World

Company Info

  • Contact Us
  • About
  • Advertise
  • Careers

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

error: Content is protected !!
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.